These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2687142

  • 21. S.E.M. study II: Protective effect of ranitidine against gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs.
    Zoli G, Pasquinelli G, Bonvicini F, Gasbarrini G, Laschi R.
    Int J Tissue React; 1986; 8(1):71-7. PubMed ID: 3949446
    [Abstract] [Full Text] [Related]

  • 22. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 23. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 24. [Epidemiology of antirheumatic drug-induced ulcer in comparison with peptic gastroduodenal ulcer. Five-year analysis of a hospital patient sample].
    Benz J, Wiedbrauck F, Hotz J.
    Med Klin (Munich); 1993 Aug 15; 88(8):463-70. PubMed ID: 8413047
    [Abstract] [Full Text] [Related]

  • 25. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Aug 15; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 26. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
    Delmas PD, Lambert R, Capron MH.
    Rev Rhum Ed Fr; 1994 Feb 15; 61(2):126-31. PubMed ID: 7920500
    [Abstract] [Full Text] [Related]

  • 27. Comparison between ranitidine 150 mg b.d. and ranitidine 300 mg nocte in the treatment of duodenal ulcer.
    Arcidiacono R, Benvestito V, Bonomo GM, Bottari M, Buscarini L, Camarri E, Celle G, Coltorti M, Di Matteo S, Dobrilla G.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul 15; 24(7):381-4. PubMed ID: 3525430
    [Abstract] [Full Text] [Related]

  • 28. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
    Young MD, Lottes SR, Webb LA.
    Clin Ther; 1988 Jul 15; 10(5):543-52. PubMed ID: 2856597
    [Abstract] [Full Text] [Related]

  • 29. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G, Lazzaroni M, Petrillo M, Manzionna G, Montrone F, Caruso I.
    Ital J Gastroenterol Hepatol; 1998 Feb 15; 30(1):43-7. PubMed ID: 9615264
    [Abstract] [Full Text] [Related]

  • 30. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI.
    Ital J Gastroenterol Hepatol; 1999 Feb 15; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [Abstract] [Full Text] [Related]

  • 31. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM.
    Am J Manag Care; 2001 Feb 15; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [Abstract] [Full Text] [Related]

  • 32. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb 15; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 33. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F, Goff J, Scowcroft C, Jennings D, Greski-Rose P.
    Am J Gastroenterol; 1994 Aug 15; 89(8):1191-200. PubMed ID: 8053433
    [Abstract] [Full Text] [Related]

  • 34. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
    Karateev AE, Murav'ev IuV, Radenska-Lopovok SG, Nasonova VA.
    Klin Med (Mosk); 2003 Aug 15; 81(8):37-41. PubMed ID: 14520944
    [Abstract] [Full Text] [Related]

  • 35. [Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases].
    Kullich W, Fromme K, Klein G.
    Wien Med Wochenschr; 1996 Aug 15; 146(17):459-64. PubMed ID: 9045528
    [Abstract] [Full Text] [Related]

  • 36. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
    Simon B, Dammann HG, Jakob G, Miederer SE, Müller P, Ottenjann R, Paul F, Scholten T, Schütz E, Seifert E.
    Z Gastroenterol; 1985 Feb 15; 23(2):47-51. PubMed ID: 2865859
    [Abstract] [Full Text] [Related]

  • 37. [Famotidine in the treatment of gastropathy induced by non-steroidal antirheumatic agents].
    Rybár I, Rovenský J, Hyrdel R.
    Vnitr Lek; 1997 Apr 15; 43(4):208-10. PubMed ID: 9601836
    [Abstract] [Full Text] [Related]

  • 38. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
    Farley A, Lévesque D, Paré P, Thomson AB, Sherbaniuk R, Archambault A, Mahoney K.
    Am J Gastroenterol; 1985 Sep 15; 80(9):665-8. PubMed ID: 3898818
    [Abstract] [Full Text] [Related]

  • 39. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 15; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 40. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, Nishigaki H, Tatsuguchi A, Futagami S, Wada K, Tsukui T, Nakajima A, Yoshino S, Sakamoto C.
    Aliment Pharmacol Ther; 2005 Jun 15; 21 Suppl 2():67-72. PubMed ID: 15943850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.